THE JUSTE GROUP CHEMISTRY
the perfect partner
THE JUSTE GROUP CHEMISTRY
the perfect partner
1922
→
HQ Madrid, Spain
Office, R&D and Manufacturing
Exporting 98% of production (45 Countries)
USA – Europe – India – Rest of World
→
 API manufacturer |
 Hospital Sales Business Unit in Spain |
W02021250163
Procedure for obtaining gadoterate meglumine
W01995026354
New iodized boron compounds
W01995026354
New non ionic iodine-contaning dimers
→
Quality Standars
→
100
YEARS
Of Experience
We offer our EUGMP plant capabilities, in Madrid (Spain) to guarantee agile development adapted to the changing circumstances of the market.
- •A qualified and multidisciplinary team, oriented to achieving results through innovation and creativity.
- • Exhaustive bibliographic studies and patent searches.
- • Route of discovery, selection and resolution of synthesis.
- • Viability assessments for reactions or essential processes.
- • Optimized development of chemical processes in early and late stages, considering small to large scale.
- • Development and validation based on analytical parameters.
- • Synthesis and purification of GMP analytical standards.
- • ICH stability studies.
Aplication
X-ray
Oral / Inyectable
ASMF
GMP
CEP
US DMF
DMF Canada
Aplication
X-ray
Inyectable
ASMF
GMP
CEP
US DMF
DMF Canada
DMF India
Aplication
X-ray
Inyectable
ASMF
GMP
CEP
US DMF
DMF Canada
DMF India
Aplication
MRI
Inyectable
ASMF
GMP
CEP
US DMF
DMF Canada
DMF India
MRI
Inyectable
ASMF
GMP
CEP
US DMF
In process
DMF Canada
DMF India
Active pharmaceutical ingredients
JUSTESA produces the following Human Health APIs:
Future portfolio
We are currently working on the development of new active pharmaceutical ingredients (APIs) for the human and veterinary pharmaceutical market.
Justesa Imagen is the perfect partner with outstanding experience in the optimization of synthesis for small molecules and the implementation of new synthetic routes that are sustainable and efficient.
- Innovation
- Patents
100 years represents a great beginning, the future starts today.
Because a large part of our scientific endeavor is based on the development of chemical processes for industrial applications.
Over the years, Justesa has boosted innovation in contrast agents, implementing efficient synthetic routes and developing chemical technology applied to industrial processes.
The best examples of this are the patents achieved.
- • WO2022129508: Organometallic compounds and their use as multi-modal contrast media for image diagnostics.
- • WO2022106715: Procedure for obtaining high-purity iohexol.
- • WO2021250163 DOTA: Procedure for obtaining gadoterate meglumine from high-purity tetraxetan (dota) and its use in preparing injectable galenic formulations.
- • WO2005115997: Trimeric macrocyclic substituted aminoisophthalate halophenyl derivatives.
- • WO2005108379: Macrocycle substituted trimer halogen-benzol derivatives.
- • EP1186305: New bromide compounds as contrast media for X-ray mammography.
Juste Quality:
Our integrated system enables us to guarantee quality through synchronized processes to ensure and improve the safety, health and environmental protection of our products through strict compliance with all regulations.
What is more, we audit and certify our systems with a constant focus on continuous improvement and customer satisfaction.
At present, we have the following certifications:
ISO 9001- Quality system certification (since 1998).
The purpose of this standard is to ensure quality management within the organization, with a clear orientation towards customer satisfaction and process management, with a focus on continuous improvement.
ISO 45001- Health and Safety system certification (since 2010, formerly OHSAS 18001).
This certification demonstrates our desire for continuous improvement in risk management for the Health and Safety, becoming more effective and efficient, reducing accidents and sickness and raising operational effectiveness.
ISO 14001- Environmental system certification (since 2004).
This standard demonstrates our commitment and responsibility to protect the environment through the management of environmental risks arising from our business activities.
Integrated Environmental authorization n.º 4.005 (Since 2008).
This standard demonstrates our commitment and responsibility to protect the environment through the management of environmental risks arising from our business activities.
Our complete quality policy, which is centered on compliance with the law as well as the demands of our customers, allows us to update and meet our commitments year after year
At present we have:
Iotalamic Acid (since 2015).
Amidotrizoic acid dihydrate
Iohexol
Iotalamic Acid
Dihexazine
Iohexol
DOTA (Tetraxetan)
Gadoterate Meglumine
To manufacture active pharmaceutical ingredients with high quality, optimizing the production processes, caring for the environment, creating efficient teams and solid alliances with our customers and generating a positive impact on our communities.
OUR VALUES:
INTEGRITY
We show moral fortitude, integrity and honesty in our conduct and behavior. We are committed to ethical, deontological values.
RESILIENCE
We are strengthening our capacity to adapt and overcome adverse situations, with a constructive approach.
COURAGE
We move forward fearlessly, with determination and strength to carry out our activity.
CURIOSITY
We are driven by the desire to learn and understand, to be at the forefront of research.
HARD WORK
We apply our energy, work and constancy to improve ourselves, aiming to achieve all our goals.
TEAM WORK
We join our forces and skills to achieve the goals we have set ourselves, achieving the best results with efficiency.
AMBITION
We want to improve, grow and advance within the framework of ethical and moral rules, pushing ourselves to achieve the most challenging results.
SOCIAL RESPONSIBILITY
we are part of our society and we want to have a positive effect on it.
